Utility of the NEONATE Score at an Institution that Routinely Performs the Hybrid Procedure for Hypoplastic Left Heart Syndrome.
Hybrid procedure
Hypoplastic left heart syndrome
Interstage
Mortality
NEONATE score
Journal
Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
18
04
2023
accepted:
26
06
2023
medline:
26
9
2023
pubmed:
27
8
2023
entrez:
26
8
2023
Statut:
ppublish
Résumé
NEONATE score > 17 has been proposed as a risk factor for interstage mortality/cardiac transplant (IM/T) for patients with single ventricle physiology. Hybrid procedure is assigned 6 points, the highest possible score for that surgical variable. Most centers reserve the hybrid procedure for high-risk patients. Goal of this study was to evaluate the NEONATE score at a center that routinely performs the hybrid procedure. Retrospective chart review of patients undergoing the hybrid procedure was performed (2008-2021). Demographics and variables used for the NEONATE score were collected. Maximization of Youden's J Statistic used to determine cohort-specific optimal threshold for patients undergoing comprehensive Stage II procedure (H-CSII) versus those with IM/T (H-IM/T). Total of 120 patients met inclusion criteria (H-CSII = 105, H-IM/T = 15). Gestational age was median 39 weeks (IQR 38, 39) and birth weight was 3.18 kg (2.91, 3.57). No patient was discharged with opiates or required post-operative extracorporeal circulatory support. Optimal threshold, as selected by maximizing Youden's J Statistic, was 22. Score > 22 had a positive predictive value of 0.33 (95% CI 0.12-0.62), negative predictive values of 0.90 (95% CI 0.83-0.95), and accuracy of 0.83 (95% CI 0.75-0.90) for IM/T. At a center that routinely performs the hybrid procedure, value of > 22 had the highest accuracy. This suggests that the hybrid procedure is not necessarily intrinsically a risk-factor for IM/T, but rather patient selection for the hybrid procedure may play a larger role at centers that do not routinely perform this procedure.
Identifiants
pubmed: 37632588
doi: 10.1007/s00246-023-03223-9
pii: 10.1007/s00246-023-03223-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1684-1690Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Ghanayem NS, Hoffman GM, Mussatto KA et al (2003) Home surveillance program prevents interstage mortality after the Norwood procedure. J Thorac Cardiovasc Surg 126(5):1367–1377
doi: 10.1016/S0022-5223(03)00071-0
pubmed: 14666008
Ghanayem NS, Allen KR, Tabbutt S et al (2012) Interstage mortality after the Norwood procedure: results of the multicenter single ventricle reconstruction trial. J Thorac Cardiovasc Surg 144(4):896–906
doi: 10.1016/j.jtcvs.2012.05.020
pubmed: 22795436
pmcid: 3985484
Ohye RG, Sleeper LA, Mahony L et al (2010) Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med 362(21):1980–1992
doi: 10.1056/NEJMoa0912461
pubmed: 20505177
pmcid: 2891109
Cua CL, Thiagarajan RR, Taeed R et al (2005) Improved interstage mortality with the modified Norwood procedure: a meta-analysis. Ann Thorac Surg 80(1):44–49
doi: 10.1016/j.athoracsur.2005.01.059
pubmed: 15975337
Meza JM, Hickey EJ, Blackstone EH et al (2017) The optimal timing of stage 2 palliation for hypoplastic left heart syndrome: an analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Data Set. Circulation 136(18):1737–1748
doi: 10.1161/CIRCULATIONAHA.117.028481
pubmed: 28687711
pmcid: 5664211
Ahmed H, Anderson JB, Bates KE et al (2020) Development of a validated risk score for interstage death or transplant after stage I palliation for single-ventricle heart disease. J Thorac Cardiovasc Surg 160(4):1021–1030
doi: 10.1016/j.jtcvs.2019.11.001
pubmed: 31924360
Wilder TJ, McCrindle BW, Hickey EJ et al (2017) Is a hybrid strategy a lower-risk alternative to stage 1 Norwood operation? J Thorac Cardiovasc Surg 153(1):163–172e166
doi: 10.1016/j.jtcvs.2016.08.021
pubmed: 27671550
Sower CT, Romano JC, Yu S, Lowery R, Pasquali SK, Zampi JD (2019) Early and midterm outcomes in high-risk single-ventricle patients: hybrid vs Norwood palliation. Ann Thorac Surg 108(6):1849–1855
doi: 10.1016/j.athoracsur.2019.06.061
pubmed: 31404546
Karamlou T, Overman D, Hill KD et al (2015) Stage 1 hybrid palliation for hypoplastic left heart syndrome—assessment of contemporary patterns of use: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. J Thorac Cardiovasc Surg 149(1):195–201 (202 e191)
doi: 10.1016/j.jtcvs.2014.08.020
pubmed: 25266878
Yates AR, Hoffman TM, Boettner B, Feltes TF, Cua CL (2011) Initial counseling prior to palliation for hypoplastic left heart syndrome. Congenit Heart Dis 6(4):347–358
doi: 10.1111/j.1747-0803.2011.00525.x
pubmed: 21696547
Galantowicz M, Cheatham JP, Phillips A et al (2008) Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve. Ann Thorac Surg 85(6):2063–2070 (discussion 2070–2061)
doi: 10.1016/j.athoracsur.2008.02.009
pubmed: 18498821
Schranz D, Bauer A, Reich B et al (2015) Fifteen-year single center experience with the “Giessen Hybrid” approach for hypoplastic left heart and variants: current strategies and outcomes. Pediatr Cardiol 36(2):365–373
doi: 10.1007/s00246-014-1015-2
pubmed: 25179460
Cua CL, McConnell PI, Meza JM et al (2018) Hybrid palliation: outcomes after the comprehensive stage 2 procedure. Ann Thorac Surg 105(5):1455–1460
doi: 10.1016/j.athoracsur.2017.11.046
pubmed: 29273201
Fenstermaker B, Berger GE, Rowland DG et al (2008) Interstage echocardiographic changes in patients undergoing hybrid stage I palliation for hypoplastic left heart syndrome. J Am Soc Echocardiogr 21(11):1222–1228
doi: 10.1016/j.echo.2008.08.005
pubmed: 18992673
Youden WJ (1950) Index for rating diagnostic tests. Cancer 3(1):32–35
doi: 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
pubmed: 15405679
Robin X, Turck N, Hainard A et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform 12:77
doi: 10.1186/1471-2105-12-77
Sunthankar SD, Zhao J, Wei WQ et al (2023) Machine learning to predict interstage mortality following single ventricle palliation: a NPC-QIC database analysis. Pediatr Cardiol 44(6):1242–1250. https://doi.org/10.1007/s00246-023-03130-z
doi: 10.1007/s00246-023-03130-z
pubmed: 36820914
Debrunner MG, Porayette P, Breinholt 3rd JP, Turrentine MW, Cordes TM (2013) Midterm survival of infants requiring postoperative extracorporeal membrane oxygenation after Norwood palliation. Pediatr Cardiol 34(3):570–575
doi: 10.1007/s00246-012-0499-x
pubmed: 23007923
Fernandez RP, Joy BF, Allen R et al (2017) Interstage survival for patients with hypoplastic left heart syndrome after ECMO. Pediatr Cardiol 38(1):50–55
doi: 10.1007/s00246-016-1483-7
pubmed: 27803957
Mitchell EA, Gomez D, Joy BF et al (2016) ECMO: incidence and outcomes of patients undergoing the hybrid procedure. Congenit Heart Dis 11(2):169–174
doi: 10.1111/chd.12311
pubmed: 27037636
Brown DW, Mangeot C, Anderson JB et al (2016) Digoxin use is associated with reduced interstage mortality in patients with no history of arrhythmia after stage I palliation for single ventricle heart disease. J Am Heart Assoc 5(1):e002376. https://doi.org/10.1161/JAHA.115.002376
doi: 10.1161/JAHA.115.002376
pubmed: 26755552
pmcid: 4859359
Truong DT, Menon SC, Lambert LM et al (2018) Digoxin use in infants with single ventricle physiology: secondary analysis of the Pediatric Heart Network Infant Single Ventricle Trial public use dataset. Pediatr Cardiol 39(6):1200–1209
doi: 10.1007/s00246-018-1884-x
pubmed: 29799077
Brown TN, Brown DW, Tweddell JS, Bates KE, Lannon CM, Anderson JB (2022) Digoxin associated with greater transplant-free survival in high- vs low-risk interstage patients. Ann Thorac Surg 114(4):1453–1459
doi: 10.1016/j.athoracsur.2021.08.082
pubmed: 34687658
Mienert T, Esmaeili A, Steinbrenner B et al (2021) Cardiovascular drug therapy during interstage after hybrid approach: a single-center experience in 51 newborns with hypoplastic left heart. Paediatr Drugs 23(2):195–202
doi: 10.1007/s40272-021-00438-2
pubmed: 33713024
pmcid: 7997825
Czosek RJ, Spar DS, Anderson JB, Khoury PR, Webster G (2022) Predictors and outcomes of arrhythmia on stage I palliation of single ventricle patients. JACC Clin Electrophysiol 8(9):1136–1144
doi: 10.1016/j.jacep.2022.06.010
pubmed: 36137719
Moore J, Paulus D, Cua CL et al (2016) Arrhythmias after stage I hybrid palliation in single-ventricle patients. Pediatr Cardiol 37(8):1416–1421
doi: 10.1007/s00246-016-1450-3
pubmed: 27425423